Beijing Strong Biotechnologies, Inc.: Announcement about not reducing the conversion price of "Jiu Qiang Convertible Bonds"
Beijing Strong Biotechnologies, Inc.: Announcement on the expected downward revision conditions of the conversion price for Jiuzhou Convertible Bonds.
Beijing Strong Biotechnologies, Inc.: Announcement on the Completion of the Implementation of Share Repurchase by the Company and Changes in Shareholding
Beijing Strong Biotechnologies, Inc.: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.
Beijing Strong Biotechnologies, Inc.: 2022, Beijing Strong Biotechnologies, Inc. issued convertible corporate bonds on the ChiNext market to unspecified buyers. A 2024 tracking rating report was also released.
Beijing Strong Biotechnologies, Inc.: Announcement on obtaining the registration certificate of medical instruments.
Beijing Strong Biotechnologies, Inc.: Growth issued convertible corporate bonds to unspecified investors with interest payable in 2024 notice.
Beijing Strong Biotechnologies, Inc.: China International Finance Co., Ltd.'s Trustee Management Report on Beijing Strong Biotechnologies, Inc.'s Issuance of Convertible Corporate Bonds to Unsolicited Parties (2023).
Beijing Strong Biotechnologies, Inc.: An indicative announcement on the resumption of share conversion of the top nine convertible bonds
Jiuqiang Biotech: Announcement on price adjustments for the top nine debt-to-equity swaps
Jiuqiang Biotech: An indicative announcement on the suspension of share conversion during the implementation of equity distribution
Jiuqiang Biotech: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Jiuqiang Biotech: Legal Opinion of Beijing Zhongzun Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Jiuqiang Biotechnology Co., Ltd.
Jiuqiang Biotech: Announcement on Obtaining a Medical Device Registration Certificate
Jiuqiang Biotech: China International Finance Corporation's 2023 Follow-up Report on Beijing Jiuqiang Biotechnology Co., Ltd.
Jiuqiang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024
Jiuqiang Biotech: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Jiuqiang Biotech: 2023 Internal Control Self-Assessment Report
Jiuqiang Biology: General Manager Work Rules
Jiuqiang Biotech: Special instructions on financial services such as deposits and loans involving transactions related to financial companies in 2023
No Data